INTERNATIONAL PATENT: TENAYA THERAPEUTICS, INC. FILES APPLICATION FOR "RHABDOVIRUS-FREE SF9 INSECT CELL LINE FOR LARGE-SCALE AAV PRODUCTION FOR CARDIOVASCULAR GENE THERAPIES"

GENEVA, Nov. 5 -- TENAYA THERAPEUTICS, INC. (171 Oyster Point Boulevard, Suite 500South San Francisco, California 94080) filed a patent application (PCT/US2025/025766) for "RHABDOVIRUS-FREE SF9 INSECT CELL LINE FOR LARGE-SCALE AAV PRODUCTION FOR CARDIOVASCULAR GENE THERAPIES" on Apr 22, 2025. With publication no. WO/2025/226680, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JING, Frank Yifeng (c/o Tenaya Therapeutics, Inc.171 Oyster Point Boulevard, Suite 500South San Francisco, California 94080), FEATHERS, Charles Jona...